TCL Archive NCAB Agrees With NCI Recommendation To Drop PO1 Chartered Committees, Adopt Single Review February 13, 1987
TCL Archive FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly. May 6, 2005
